3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
1
Interventions
Radiotherapy
10
Cisplatin
10
Carboplatin
7
Capecitabine
6
Neoadjuvant Therapy
5
Gemcitabine
5
Fluorouracil
5
Docetaxel
5
Paclitaxel
4
Cyclophosphamide
4
Trastuzumab
3
Tamoxifen
3
Surgical Procedures, Operative
3
Radiation
3
Oxaliplatin
3
Hydralazine
3
Etoposide
3
Drug Therapy
3
pertuzumab
2
pegylated granulocyte colony-stimulating factor
2
palbociclib
2
endostar protein
2
Valproic Acid
2
Tranexamic Acid
2
Temozolomide
2
TP protocol
2
Saline Solution
2
Radiotherapy, Adjuvant
2
Proton Pump Inhibitors
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
OTHER_GOV
×
Technetium
×
Clear all
NCT07552597
2026-04-27
MagMen-II
Vastra Gotaland Region
Phase 3
Not yet recruiting
254 enrolled